Is insulin-like growth factor-1 involved in Parkinson’s disease development?

Parkinson’s disease (PD) is a neurodegenerative disorder that results in the death of dopaminergic neurons within the substantia nigra pars compacta and the reduction in dopaminergic control over striatal output neurons, leading to a movement disorder most commonly characterized by akinesia or brady...

Descripción completa

Detalles Bibliográficos
Autores principales: Castilla-Cortázar, Inma, Aguirre, Gabriel A., Femat-Roldán, Giovana, Martín-Estal, Irene, Espinosa, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014772/
https://www.ncbi.nlm.nih.gov/pubmed/32046737
http://dx.doi.org/10.1186/s12967-020-02223-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014772/
https://www.ncbi.nlm.nih.gov/pubmed/32046737
http://dx.doi.org/10.1186/s12967-020-02223-0

Ejemplares similares